Literature DB >> 7577664

Hypothalamic hamartoma and the Pallister-Hall syndrome.

L A Squires1, S Constantini, D C Miller, J H Wisoff.   

Abstract

The Pallister-Hall syndrome (PHS) was initially described as the congenital hypothalamic 'hamartoblastoma' syndrome in 1980. Cardinal manifestations of the syndrome consist of a hypothalamic hamartoma and extracranial abnormalities, initially thought to be fatal in the perinatal period. The original pathologic description of these hypothalamic lesions were from infants who died in the perinatal period and revealed small cells of variable density which resembled primitive undifferentiated germinal cells and appeared to invade the hypothalamic nuclei, suggesting a neoplastic potential. Hypothalamic lesions have now been removed from older infants and children with this syndrome and reveal a more mature histologic appearance typical of a hypothalamic hamartoma. We present 2 new cases of PHS who underwent surgery and demonstrate the maturational nature of the hypothalamic lesion and the phenotypic variability of the syndrome.

Entities:  

Mesh:

Year:  1995        PMID: 7577664     DOI: 10.1159/000120920

Source DB:  PubMed          Journal:  Pediatr Neurosurg        ISSN: 1016-2291            Impact factor:   1.162


  2 in total

1.  Pallister-Hall syndrome: clinical and MR features.

Authors:  J S Kuo; S O Casey; L Thompson; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

Review 2.  Neuroimaging appearance of hypothalamic hamartomas in monozygotic twins with Pallister-Hall syndrome: case report and review of the literature.

Authors:  Alessandra Consales; Giulia Ardemani; Claudia Maria Cinnante; Mariana Rita Catalano; Claudia Giavoli; Roberta Villa; Maria Iascone; Camilla Fontana; Maria Francesca Bedeschi; Monica Fumagalli
Journal:  BMC Neurol       Date:  2022-03-24       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.